New York State Common Retirement Fund’s Nautilus Biotechnolgy NAUT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26.2K Buy
+14,000
New +$37K ﹤0.01% 3100
2025
Q2
– Sell
-8,626
Closed -$7.43K – 3286
2025
Q1
$7.43K Hold
8,626
– – ﹤0.01% 3104
2024
Q4
$14.5K Hold
8,626
– – ﹤0.01% 3087
2024
Q3
$24.6K Hold
8,626
– – ﹤0.01% 3014
2024
Q2
$20.2K Sell
8,626
-1
-0% -$3 ﹤0.01% 3210
2024
Q1
$25.4K Sell
8,627
-55
-0.6% -$156 ﹤0.01% 3117
2023
Q4
$26K Sell
8,682
-49
-0.6% -$140 ﹤0.01% 3122
2023
Q3
$27.6K Buy
8,731
+131
+2% +$426 ﹤0.01% 3146
2023
Q2
$33.3K Sell
8,600
-26,000
-75% -$74.9K ﹤0.01% 3197
2023
Q1
$95.8K Hold
34,600
– – ﹤0.01% 2828
2022
Q4
$62.3K Hold
34,600
– – ﹤0.01% 3056
2022
Q3
$73K Buy
34,600
+400
+1% +$1.01K ﹤0.01% 3080
2022
Q2
$92K Buy
+34,200
New +$127K ﹤0.01% 3094

Other funds holding NAUT

New York State Common Retirement Fund's NAUT Position: Q2 2026 in Review

New York State Common Retirement Fund opened a new position in Nautilus Biotechnolgy (NAUT) in Q2 2026: 14,000 shares worth $26.2K. The stake represents ﹤0.01% of the portfolio and ranks #3100 among its holdings. This is a return to the name: New York State Common Retirement Fund previously reported a position in NAUT as recently as Q1 2025.

New York State Common Retirement Fund first reported a position in NAUT in Q2 2022 and has held it in 13 quarters since. The position peaked at $95.8K in Q1 2023. 93 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.

  • New York State Common Retirement Fund held 14,000 shares of Nautilus Biotechnolgy worth $26.2K as of Q2 2026.
  • Nautilus Biotechnolgy was a new New York State Common Retirement Fund position in Q2 2026.
  • Nautilus Biotechnolgy made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #3100 holding.
  • New York State Common Retirement Fund first reported a position in Nautilus Biotechnolgy in Q2 2022 and has held it in 13 quarters since.
  • New York State Common Retirement Fund's Nautilus Biotechnolgy position peaked at $95.8K in Q1 2023.
  • 93 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.